Nurix Therapeutics, Inc.
NRIX
$13.59
$0.403.03%
11/30/2024 | 08/31/2024 | ||||
---|---|---|---|---|---|
Revenue | 5.53% | 4.10% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 5.53% | 4.10% | |||
Cost of Revenue | 21.17% | 13.41% | |||
Gross Profit | -25.75% | -16.46% | |||
SG&A Expenses | -8.54% | 0.07% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 15.99% | 10.83% | |||
Operating Income | -18.40% | -12.51% | |||
Income Before Tax | -19.78% | -9.94% | |||
Income Tax Expenses | -90.24% | -8.89% | |||
Earnings from Continuing Operations | -19.60% | -9.90% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -19.60% | -9.90% | |||
EBIT | -18.40% | -12.51% | |||
EBITDA | -21.43% | -13.00% | |||
EPS Basic | -11.00% | 5.80% | |||
Normalized Basic EPS | -11.17% | 5.77% | |||
EPS Diluted | -11.00% | 5.80% | |||
Normalized Diluted EPS | -11.17% | 5.77% | |||
Average Basic Shares Outstanding | 7.74% | 16.68% | |||
Average Diluted Shares Outstanding | 7.74% | 16.68% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |